Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Germain

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Enzyme|January 1, 1979
Effects of metal ions and selenoamino acids on induction of glutathione peroxidase in mouse neuroblastomaG S Germain, R M Arneson
Lipids|June 1, 1978
Antioxidants in neoplastic cells: I. Changes in the antioxidative capacity of mouse neuroblastoma cells measured by a single-phase assayR M Arneson, V J Aloyo, G S Germain, et al.
Biochemical Pharmacology|May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug actionJ Sosinski, J H Thakar, G S Germain, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiencyP J Houghton, G S Germain, B J Hazelton, et al.
Oncology Research|June 5, 1998
Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cellsK N Thimmaiah, B S Jayashree, G S Germain, et al.
Cancer Research|February 15, 1994
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptorM B Dilling, P Dias, D N Shapiro, et al.
Biochemical Pharmacology|April 1, 1990
Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-ureaP J Houghton, F C Bailey, G S Germain, et al.
Cancer Research|January 15, 1990
N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cellsP J Houghton, F C Bailey, G S Germain, et al.
Molecular Pharmacology|May 1, 1994
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)ureaJ Sosinski, J H Thakar, G S Germain, et al.
Cancer Research|September 15, 1990
Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell lineD N Shapiro, P J Houghton, B J Hazelton, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Enzyme|January 1, 1979
Effects of metal ions and selenoamino acids on induction of glutathione peroxidase in mouse neuroblastomaG S Germain, R M Arneson
Lipids|June 1, 1978
Antioxidants in neoplastic cells: I. Changes in the antioxidative capacity of mouse neuroblastoma cells measured by a single-phase assayR M Arneson, V J Aloyo, G S Germain, et al.
Biochemical Pharmacology|May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug actionJ Sosinski, J H Thakar, G S Germain, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiencyP J Houghton, G S Germain, B J Hazelton, et al.
Oncology Research|June 5, 1998
Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cellsK N Thimmaiah, B S Jayashree, G S Germain, et al.
Cancer Research|February 15, 1994
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptorM B Dilling, P Dias, D N Shapiro, et al.
Biochemical Pharmacology|April 1, 1990
Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-ureaP J Houghton, F C Bailey, G S Germain, et al.
Cancer Research|January 15, 1990
N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cellsP J Houghton, F C Bailey, G S Germain, et al.
Molecular Pharmacology|May 1, 1994
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)ureaJ Sosinski, J H Thakar, G S Germain, et al.
Cancer Research|September 15, 1990
Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell lineD N Shapiro, P J Houghton, B J Hazelton, et al.
Pageof 2